1. Home
  2. KRO vs PHAR Comparison

KRO vs PHAR Comparison

Compare KRO & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kronos Worldwide Inc

KRO

Kronos Worldwide Inc

HOLD

Current Price

$6.42

Market Cap

760.5M

Sector

Industrials

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$13.18

Market Cap

885.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRO
PHAR
Founded
1916
1988
Country
United States
Netherlands
Employees
N/A
409
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
760.5M
885.7M
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
KRO
PHAR
Price
$6.42
$13.18
Analyst Decision
Strong Sell
Strong Buy
Analyst Count
2
3
Target Price
$6.00
$38.33
AVG Volume (30 Days)
258.0K
14.5K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
2.79%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,859,400,000.00
N/A
Revenue This Year
$6.75
$10.04
Revenue Next Year
$8.36
$2.51
P/E Ratio
N/A
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$4.08
$9.54
52 Week High
$7.89
$21.34

Technical Indicators

Market Signals
Indicator
KRO
PHAR
Relative Strength Index (RSI) 41.12 40.17
Support Level $6.08 $11.84
Resistance Level $6.71 $13.61
Average True Range (ATR) 0.30 0.45
MACD -0.06 0.07
Stochastic Oscillator 1.36 45.60

Price Performance

Historical Comparison
KRO
PHAR

About KRO Kronos Worldwide Inc

Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The maximum of revenue comes from the United States.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: